CN103720918B - A kind of Chinese medicine composition for the treatment of jaundice - Google Patents

A kind of Chinese medicine composition for the treatment of jaundice Download PDF

Info

Publication number
CN103720918B
CN103720918B CN201410011224.2A CN201410011224A CN103720918B CN 103720918 B CN103720918 B CN 103720918B CN 201410011224 A CN201410011224 A CN 201410011224A CN 103720918 B CN103720918 B CN 103720918B
Authority
CN
China
Prior art keywords
parts
jaundice
chinese medicine
medicine composition
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410011224.2A
Other languages
Chinese (zh)
Other versions
CN103720918A (en
Inventor
冯萍
陈立娥
胡小梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410011224.2A priority Critical patent/CN103720918B/en
Publication of CN103720918A publication Critical patent/CN103720918A/en
Application granted granted Critical
Publication of CN103720918B publication Critical patent/CN103720918B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a kind of Chinese medicine composition for the treatment of jaundice, be made up of the raw material of following weight proportioning: Herba Taraxaci 10-40 part, Cornu Saigae Tataricae 20-50 part, Herba Artemisiae Scopariae 30-80 part, Lycopodium clavatum 30-80 part, bee corpse 50-120 part, Gekko Swinhonis 20-70 part, Lignum Aquilariae Resinatum 20-70 part, Hirudo 20-50 part, Formica fusca 30-80 part, Polyporus 30-60 part, live loacs 1000-3000 part, crab apple 20-60 part.The present invention treats that the Chinese medicine composition of jaundice is raw materials used is natural Chinese medicine, and medicine source is extensively easy to get, and all medicine compatibilities complement each other, and treatment jaundice is evident in efficacy, and has no side effect.

Description

A kind of Chinese medicine composition for the treatment of jaundice
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of jaundice.
Background technology
Jaundice is common sympton and sign, and it to cause in serum caused by bilirubin concentration raises.Clinical signs is that sclera, mucosa, skin and hetero-organization thereof are dyed to yellow.Because sclera contains more elasticin, have stronger affinity with bilirubin, therefore Patients with Jaundice yellow sclera is often prior to mucosa, skin and first being discovered.When serum total bilirubin is at 17.1 ~ 34.2 μm of ol/L, and when naked eyes do not see jaundice, claim latent jaundice or subclinical jaundice; When bloodstain total bilirubin concentration is more than 34.2 μm of ol/L, jaundice can be found clinically, also referred to as clinical jaundice.
Jaundice Producing reason mainly contains: bilirubin generates too much; Hepatocyte function is low or have function hepatocyte amount to reduce; Liver cell destruction conjugated bilirubin is excessive; Liver inner mold cholestasis; Blocking of large bile duct.The side effect brought due to Chinese medicine composition is very little, therefore adopt traditional Chinese medicine composition for treating jaundice very general, but because jaundice is because of many, often therapeutic effect is not obvious.
Summary of the invention
The object of the present invention is to provide the Chinese medicine composition for the treatment of jaundice that a kind of crude drug source is extensive, evident in efficacy, have no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of jaundice, is made up of the raw material of following weight proportioning: Herba Taraxaci 10-40 part, Cornu Saigae Tataricae 20-50 part, Herba Artemisiae Scopariae 30-80 part, Lycopodium clavatum 30-80 part, bee corpse 50-120 part, Gekko Swinhonis 20-70 part, Lignum Aquilariae Resinatum 20-70 part, Hirudo 20-50 part, Formica fusca 30-80 part, Polyporus 30-60 part, live loacs 1000-3000 part, crab apple 20-60 part.
Preferably, the Chinese medicine composition of described treatment jaundice is made up of the raw material of following weight proportioning: Herba Taraxaci 20-30 part, Cornu Saigae Tataricae 20-40 part, Herba Artemisiae Scopariae 50-60 part, Lycopodium clavatum 50-60 part, bee corpse 80-100 part, Gekko Swinhonis 40-60 part, Lignum Aquilariae Resinatum 40-60 part, Hirudo 20-40 part, Formica fusca 50-60 part, Polyporus 30-50 part, live loacs 1500-2000 part, crab apple 40-60 part.
Preferably, the Chinese medicine composition of described treatment jaundice is made up of the raw material of following weight proportioning: Herba Taraxaci 30 parts, Cornu Saigae Tataricae 40 parts, Herba Artemisiae Scopariae 50 parts, Lycopodium clavatum 50 parts, bee corpse 100 parts, Gekko Swinhonis 40 parts, Lignum Aquilariae Resinatum 40 parts, Hirudo 40 parts, Formica fusca 50 parts, Polyporus 50 parts, live loacs 2000 parts, crab apple 40 parts.
First live loacs is put in clear water and support 1 day, make its emptying enteral refuse, put again next day in drying baker and dry or dry that to grind bottling into powder for subsequent use; Other medicines are dried and are ground to the powder altogether, and then with Misgurni anguillicaudati powder mixing, 5g for oral administration at every turn, every day 2 times 30 days was 1 course for the treatment of.
The pharmacologically active of each crude drug of the present invention is as follows:
Herba Taraxaci, bitter in the mouth, sweet, cold, return liver, stomach warp, containing multiple health-nutrition compositions such as taraxol, taraxacin, choline, organic acid, inulin, have the merit of heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, dampness removing jaundice eliminating, treating stranguria pain relieving.
Cornu Saigae Tataricae, salty in the mouth, cold in nature, return liver, heart channel, there is heat clearing away relieving convulsion, suppressing the hyperactive liver to relieve the wind syndrome, improving acuity of vision and removing nebula, effect of removing pathogenic heat from blood and toxic substance from the body.
Herba Artemisiae Scopariae, bitter, pungent, be slightly cold, return spleen, stomach, liver, gallbladder meridian, Herba Artemisiae Scopariae clearing away heat-damp and promoting diuresis; Jaundice eliminating, cure mainly jaundice, dysuria, eczema pruritus, infectious jaundice type hepatitis etc., modern pharmacological research confirms, Herba Artemisiae Scopariae obviously can alleviate the pathological change of Hepatocellular ballooning and necrosis, and have the effect of repairing hepatocyte structure and recovering its function, thus reduce serum transaminase vigor.
Lycopodium clavatum, micro-hardship, pungent, temperature, returns liver,spleen,kidney warp, expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral.
Bee corpse, Formica fusca contain and the multiple organic acid such as the plurality of inorganic salt of human serum concentration comparable and vitamin, ferrum, calcium, copper, manganese, potassium, phosphorus, and patient can be helped to supplement the trace element of health.
Gekko Swinhonis, salty, cold, slightly poisonous, dispel the wind, active, eliminating stagnation.
Lignum Aquilariae Resinatum, acrid, bitter, warm, return spleen, stomach, kidney, lung meridian, treating the liver is strongly fragrant, falls irritability, and taste, and disappear dampness, and diuretic is had one's ideas straightened out.
Hirudo, salty, bitter, flat, slightly poisonous, return liver, kidney channel.
Polyporus, sweet in the mouth, light, flat, GUIXIN, spleen, stomach, lung, kidney channel, have diuresis to harness the river swollen effect, containing polyporusum bellatus, test can be anticancer.
Live loacs, sweet in the mouth, property are flat, return spleen, liver, kidney channel, invigorating spleen and kidney, diuretic, removing toxic substances, and also containing abundant nucleoside in Misgurni anguillicaudati body, nucleoside is the main component of various vaccine, can improve health anti-virus ability.
Crab apple, sour, sweet, slightly warm in nature, returns spleen, stomach, Liver Channel, and the immunity of energy enhancing body, has the effect of dissipating blood stasis of having a respite.
The present invention has following beneficial effect: the present invention treats that the Chinese medicine composition of jaundice is raw materials used is natural Chinese medicine, and medicine source is extensively easy to get, and all medicine compatibilities complement each other, and treatment jaundice is evident in efficacy, and has no side effect.
Detailed description of the invention
Be below specific embodiments of the invention, technical scheme of the present invention is done to describing further, but protection scope of the present invention be not limited to these embodiments.Every do not deviate from the present invention's design change or equivalent substituting include within protection scope of the present invention.
Embodiment 1
Treat a Chinese medicine composition for jaundice, be made up of the raw material of following weight proportioning: Herba Taraxaci 10 parts, Cornu Saigae Tataricae 30 parts, Herba Artemisiae Scopariae 60 parts, Lycopodium clavatum 80 parts, bee corpse 50 parts, Gekko Swinhonis 50 parts, Lignum Aquilariae Resinatum 20 parts, Hirudo 30 parts, Formica fusca 80 parts, Polyporus 60 parts, live loacs 1000 parts, crab apple 60 parts.
Embodiment 2
Treat a Chinese medicine composition for jaundice, be made up of the raw material of following weight proportioning: Herba Taraxaci 30 parts, Cornu Saigae Tataricae 40 parts, Herba Artemisiae Scopariae 50 parts, Lycopodium clavatum 50 parts, bee corpse 100 parts, Gekko Swinhonis 40 parts, Lignum Aquilariae Resinatum 40 parts, Hirudo 40 parts, Formica fusca 50 parts, Polyporus 50 parts, live loacs 2000 parts, crab apple 40 parts.
Embodiment 3
Treat a Chinese medicine composition for jaundice, be made up of the raw material of following weight proportioning: Herba Taraxaci 20 parts, Cornu Saigae Tataricae 50 parts, Herba Artemisiae Scopariae 80 parts, Lycopodium clavatum 30 parts, bee corpse 120 parts, Gekko Swinhonis 70 parts, Lignum Aquilariae Resinatum 50 parts, Hirudo 50 parts, Formica fusca 30 parts, Polyporus 40 parts, live loacs 1000 parts, crab apple 50 parts.
Embodiment 4
Treat a Chinese medicine composition for jaundice, be made up of the raw material of following weight proportioning: Herba Taraxaci 30 parts, Cornu Saigae Tataricae 20 parts, Herba Artemisiae Scopariae 30 parts, Lycopodium clavatum 60 parts, bee corpse 70 parts, Gekko Swinhonis 20 parts, Lignum Aquilariae Resinatum 70 parts, Hirudo 20 parts, Formica fusca 70 parts, Polyporus 30 parts, live loacs 3000 parts, crab apple 20 parts.
In the present invention, the using method of compositions is: first live loacs is put in clear water and support 1 day, make its emptying enteral refuse, is put next day in drying baker to dry or dry that to grind bottling into powder for subsequent use again; Other medicines are dried and are ground to the powder altogether, and then with Misgurni anguillicaudati powder mixing, 5g for oral administration at every turn, every day 2 times 30 days was 1 course for the treatment of.
Utilize Chinese medicine preparation of the present invention to the Patients with Jaundice clinical treatment observation of 76 routine different pathogenies, in the course for the treatment of, cure rate reaches 72.4% (curing 55 examples), cure rate 94.7% (curing 71 examples altogether) in two courses for the treatment of, invalid 5 examples, evident in efficacy, cure rate is high, and has no side effect.
Model case:
Case 1: Zhao * *, man, 48 years old, to coerce pain to examine, card meeting was yellow, spiritlessness and weakness, and with heating, poor appetite, nausea and vomiting, pain that hepatic region is swollen, red tongue, yellow fur, stringy and rolling pulse number.Laboratory checks that leukocyte is normal slightly low and normal, and lymphocyte increases relatively.Liver function test serum paddy third turn of ammonia, apparently higher than normally, is greater than normal peak more than 4 times, B ultrasonic: hepatocyte luminous point increases thick, enhancing change.Be diagnosed as icterohepatitis, controlling should heat-clearing and dampness-resolving.Check after 15 days with this side treatment, transaminase, liver function indices decline 25-50%; Continue with 15 days, liver and spleen retraction is to normal, and hepatic region is without obvious tenderness and percussion pain, and healing is left hospital.Advise it to avoid the dietary habit such as tobacco and wine, Fructus Capsici, fat meat, keep happy, take a good rest.Follow up a case by regular visits to 2 years without recurrence.
Case 2: what *, female, 35 years old, within one week, feel sick, detest greasy, indigestion and loss of appetite, xerostomia is bitter, weak, yellowish urine as tea, find appearance jaundice in a couple of days, health slightly feels pruritus, the miserable discomfort of eyes.Through looking into icteric index 60 unit, bilirubin > 4 milligrams of %, glutamate pyruvate transaminase 440 only position, Archon protein ratio 3.97/4.2S, cholesterol 216.1mg%, HBsAg1: 16, be diagnosed as acute jaundice hepatitis B.After taking a course for the treatment of of Chinese medicine composition of the present invention, patient's subjective symptoms disappears, check icteric index 4 unit, and bilirubin is milligram % o.4, and glutamate pyruvate transaminase test recovers normal, albumin, globulin ratio 4.7 3.17, HBsAs cloudyly to turn.Continue to take Chinese medicine composition of the present invention 15 days, liver function is normal, and HBsAg is negative, Archon protein ratio 4.62 3.02, cure.Follow up a case by regular visits to 1 year without recurrence.

Claims (3)

1. treat a Chinese medicine composition for jaundice, it is characterized in that, be made up of the raw material of following weight proportioning: Herba Taraxaci 10-40 part, Cornu Saigae Tataricae 20-50 part, Herba Artemisiae Scopariae 30-80 part, Lycopodium clavatum 30-80 part, bee corpse 50-120 part, Gekko Swinhonis 20-70 part, Lignum Aquilariae Resinatum 20-70 part, Hirudo 20-50 part, Formica fusca 30-80 part, Polyporus 30-60 part, live loacs 1000-3000 part, crab apple 20-60 part.
2. the Chinese medicine composition for the treatment of jaundice according to claim 1, is characterized in that, is made up of the raw material of following weight proportioning: Herba Taraxaci 20-30 part, Cornu Saigae Tataricae 20-40 part, Herba Artemisiae Scopariae 50-60 part, Lycopodium clavatum 50-60 part, bee corpse 80-100 part, Gekko Swinhonis 40-60 part, Lignum Aquilariae Resinatum 40-60 part, Hirudo 20-40 part, Formica fusca 50-60 part, Polyporus 30-50 part, live loacs 1500-2000 part, crab apple 40-60 part.
3. the Chinese medicine composition for the treatment of jaundice according to claim 1 and 2, is characterized in that, is made up of the raw material of following weight proportioning: Herba Taraxaci 30 parts, Cornu Saigae Tataricae 40 parts, Herba Artemisiae Scopariae 50 parts, Lycopodium clavatum 50 parts, bee corpse 100 parts, Gekko Swinhonis 40 parts, Lignum Aquilariae Resinatum 40 parts, Hirudo 40 parts, Formica fusca 50 parts, Polyporus 50 parts, live loacs 2000 parts, crab apple 40 parts.
CN201410011224.2A 2014-01-09 2014-01-09 A kind of Chinese medicine composition for the treatment of jaundice Expired - Fee Related CN103720918B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410011224.2A CN103720918B (en) 2014-01-09 2014-01-09 A kind of Chinese medicine composition for the treatment of jaundice

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410011224.2A CN103720918B (en) 2014-01-09 2014-01-09 A kind of Chinese medicine composition for the treatment of jaundice

Publications (2)

Publication Number Publication Date
CN103720918A CN103720918A (en) 2014-04-16
CN103720918B true CN103720918B (en) 2016-04-20

Family

ID=50445380

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410011224.2A Expired - Fee Related CN103720918B (en) 2014-01-09 2014-01-09 A kind of Chinese medicine composition for the treatment of jaundice

Country Status (1)

Country Link
CN (1) CN103720918B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1197673A (en) * 1998-04-01 1998-11-04 王凤贤 Chinese medicine 'Xiaoyangtang' for curing acute and chronic hepatitis B
CN101757509A (en) * 2009-11-04 2010-06-30 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating icterohepatitis and preparation method thereof
CN102068566A (en) * 2009-11-19 2011-05-25 天津中新药业集团股份有限公司乐仁堂制药厂 Quality control method for Yinchen Wudan pills for treating damp-heat jaundice
CN103120732A (en) * 2011-11-18 2013-05-29 北京亚东生物制药有限公司 Chinese medicinal composition for treating jaundice and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1197673A (en) * 1998-04-01 1998-11-04 王凤贤 Chinese medicine 'Xiaoyangtang' for curing acute and chronic hepatitis B
CN101757509A (en) * 2009-11-04 2010-06-30 泰一和浦(北京)中医药研究院有限公司 Traditional Chinese medicine composition for treating icterohepatitis and preparation method thereof
CN102068566A (en) * 2009-11-19 2011-05-25 天津中新药业集团股份有限公司乐仁堂制药厂 Quality control method for Yinchen Wudan pills for treating damp-heat jaundice
CN103120732A (en) * 2011-11-18 2013-05-29 北京亚东生物制药有限公司 Chinese medicinal composition for treating jaundice and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"痰瘀兼治法辩治黄疸四则";闫惠狭等;《河南中医》;20081010;第28卷(第10期);全文 *
"验方治黄疸";唐德江;《医药与保健》;19960805;全文 *

Also Published As

Publication number Publication date
CN103720918A (en) 2014-04-16

Similar Documents

Publication Publication Date Title
CN102688420B (en) Traditional Chinese medicine decoction for treating psoriasis
CN102526502A (en) Chinese medicine preparation for treating myasthenia gravis
CN103223131A (en) Liver disease drug
CN103263629B (en) Medical wine and preparation method thereof
CN103720918B (en) A kind of Chinese medicine composition for the treatment of jaundice
CN107007784A (en) Chinese medicine composition for reversing A amyloid beta damaged nerve cells and preparation method and application
CN1175884C (en) Kidney-reinforcing Yang-invigorating pill for treating sexual impotence, and preparing process thereof
CN101095779A (en) Chinese patent drug for treating diabetes erysipelas
CN104491585A (en) Paste with effects of expelling wind and removing dampness for rheumatic arthritis and preparation method of paste
CN101028491A (en) Chinese-medicinal preparation for treating ribbon bleb
CN103705811A (en) External traditional Chinese medicine preparation for treating tinea unguium and preparation method thereof
CN102366484A (en) Pharmaceutical composition for treating herpes zoster and preparation method thereof
CN103386101A (en) Traditional Chinese medicine preparation for nonspecific cystitis treatment and preparation method thereof
CN100496594C (en) Gastropathy treating Chinese medicine composition
CN101259187A (en) Medicaments assembly for treating eczema and preparation thereof
CN105920208A (en) Medicinal composition for treating infantile wind-heat type common cold
CN1259949C (en) Capsule for treating wound
CN101085312A (en) Traditional Chinese medicine for treating hyperdyroidism
CN104042800A (en) Compound traditional Chinese medicine preparation for treating herpes simplex and preparation method thereof
CN105381346A (en) Traditional Chinese medicine for treating proteinuria
CN105214065A (en) External chilblain is loose, preparation technology and using method thereof
CN103494986A (en) Traditional Chinese medicine for treating primary trigeminal neuralgia
CN103623156B (en) One treats hypertensive Chinese medicine composition
CN102824609A (en) Medicine for treating gynecological inflammation and preparation method thereof
CN101112476A (en) Chinese traditional medicine composition for treating mycotic vaginitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160420

Termination date: 20170109

CF01 Termination of patent right due to non-payment of annual fee